BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 35624326)

  • 21. Development and Validation of a Patient-reported Score to Screen for Mucosal Inflammation in Inflammatory Bowel Disease.
    de Jong MJ; Roosen D; Degens JHRJ; van den Heuvel TRA; Romberg-Camps M; Hameeteman W; Bodelier AGL; Romanko I; Lukas M; Winkens B; Markus T; Masclee AAM; van Tubergen A; Jonkers DMAE; Pierik MJ
    J Crohns Colitis; 2019 Apr; 13(5):555-563. PubMed ID: 30476099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thiopurine Monotherapy Is Effective in Maintenance of Mild-Moderate Inflammatory Bowel Disease.
    Barber GE; Hendler S; Choe M; Keyashian K; Lechner S; Limketkai BN; Limsui D
    Dig Dis Sci; 2022 Apr; 67(4):1287-1294. PubMed ID: 33755823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammatory bowel disease in a colorectal cancer screening population: Diagnosis and follow-up.
    Bezzio C; Manes G; Schettino M; Arena I; de Nucci G; Della Corte C; Devani M; Mandelli E; Morganti D; Omazzi B; Pellegrini L; Picascia D; Redaelli D; Reati R; Saibeni S
    Dig Liver Dis; 2021 May; 53(5):587-591. PubMed ID: 32863160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indicators of suboptimal response to anti-tumor necrosis factor therapy in patients from China with inflammatory bowel disease: results from the EXPLORE study.
    Li J; Liu Z; Hu P; Wen Z; Cao Q; Zou X; Chen Y; Wang Y; Zhong J; Shen X; Demuth D; Fadeeva O; Xie L; Chen J; Qian J
    BMC Gastroenterol; 2022 Feb; 22(1):44. PubMed ID: 35120446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occurrence of Colorectal Cancer After a Negative Colonoscopy in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Scotti GB; Iannone I; DE Padua C; Crocetti D; Fiori G; Sapienza P; Fiori E; Avenia S; Lamazza A
    In Vivo; 2024; 38(2):523-530. PubMed ID: 38418112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biologic Use Patterns and Predictors for Non-persistence and Switching of Biologics in Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study.
    Jung YS; Han M; Park S; Cheon JH
    Dig Dis Sci; 2020 May; 65(5):1436-1444. PubMed ID: 31677070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal Manifestations in Inflammatory Bowel Disease: A Cohort Study During the Biologic Era.
    Dincer MT; Dincer ZT; Bakkaloglu OK; Yalin SF; Trabulus S; Celik AF; Seyahi N; Altiparmak MR
    Med Sci Monit; 2022 Jul; 28():e936497. PubMed ID: 35791280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children.
    Yang Z; Clark N; Park KT
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):253-62.e2. PubMed ID: 23883663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Comprehensive Global Population-Based Analysis on the Coexistence of Eosinophilic Esophagitis and Inflammatory Bowel Disease.
    Malik A; Liu BD; Zhu L; Kaelber D; Song G
    Dig Dis Sci; 2024 Mar; 69(3):892-900. PubMed ID: 38218734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
    Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis change in pediatric inflammatory bowel disease.
    Duarte H; Stolfi A; McCall C; Saeed S; Sandberg K
    J Pediatr Gastroenterol Nutr; 2024 Mar; 78(3):623-633. PubMed ID: 38504401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Usefulness of Serum Vitamin D Levels in the Assessment of IBD Activity and Response to Biologics.
    Valvano M; Magistroni M; Mancusi A; D'Ascenzo D; Longo S; Stefanelli G; Vernia F; Viscido A; Necozione S; Latella G
    Nutrients; 2021 Jan; 13(2):. PubMed ID: 33499406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Declining Rates of Surgery for Inflammatory Bowel Disease in the Era of Biologic Therapy.
    Lowe SC; Sauk JS; Limketkai BN; Kwaan MR
    J Gastrointest Surg; 2021 Jan; 25(1):211-219. PubMed ID: 33140318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimizing Selection of Biologics in Inflammatory Bowel Disease: Development of an Online Patient Decision Aid Using Conjoint Analysis.
    Almario CV; Keller MS; Chen M; Lasch K; Ursos L; Shklovskaya J; Melmed GY; Spiegel BMR
    Am J Gastroenterol; 2018 Jan; 113(1):58-71. PubMed ID: 29206816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utilization of Colonoscopy Following Treatment Initiation in U.S. Commercially Insured Patients With Inflammatory Bowel Disease, 2013-2019.
    Yang JY; Lund JL; Pate V; Kappelman MD
    Inflamm Bowel Dis; 2023 May; 29(5):735-743. PubMed ID: 35929644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intestinal Barrier Healing Is Superior to Endoscopic and Histologic Remission for Predicting Major Adverse Outcomes in Inflammatory Bowel Disease: The Prospective ERIca Trial.
    Rath T; Atreya R; Bodenschatz J; Uter W; Geppert CE; Vitali F; Fischer S; Waldner MJ; Colombel JF; Hartmann A; Neurath MF
    Gastroenterology; 2023 Feb; 164(2):241-255. PubMed ID: 36279923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utilization of Treat-to-Target Monitoring Colonoscopy After Treatment Initiation in the US-Based Study of a Prospective Adult Research Cohort With Inflammatory Bowel Disease.
    Yang JY; Lund JL; Funk MJ; Hudgens MG; Lewis JD; Kappelman MD;
    Am J Gastroenterol; 2023 Sep; 118(9):1638-1647. PubMed ID: 37053548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased risk of pneumonia among patients with inflammatory bowel disease.
    Long MD; Martin C; Sandler RS; Kappelman MD
    Am J Gastroenterol; 2013 Feb; 108(2):240-8. PubMed ID: 23295276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of plasma alternative to serum for measuring leucine-rich α2-glycoprotein as a biomarker of inflammatory bowel disease.
    Ichimiya T; Kazama T; Ishigami K; Yokoyama Y; Hayashi Y; Takahashi S; Itoi T; Nakase H
    PLoS One; 2023; 18(6):e0286415. PubMed ID: 37352151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rates and characteristics of postcolonoscopy colorectal cancer in the Swedish IBD population: what are the differences from a non-IBD population?
    Stjärngrim J; Ekbom A; Hammar U; Hultcrantz R; Forsberg AM
    Gut; 2019 Sep; 68(9):1588-1596. PubMed ID: 30554159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.